Similar articles

• [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].

  Kolloch R, Stumpe KO, Higuchi M, Vetter H, Krück F. Kolloch R, et al. Klin Wochenschr. 1977 Oct 15;55(20):1013-8. doi: 10.1007/BF01488188. Klin Wochenschr. 1977. PMID: 926711 German.
• [Decreased excitability of renin secretion in patients with essential hypertension].

  Lange HH, Held E, Weber PC. Lange HH, et al. Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:287-90. Verh Dtsch Ges Inn Med. 1977. PMID: 611965 German. No abstract available.
• [Hemodynamic and biological effects of bromocriptine in essential hypertension].

  Allain H, Daubert JC, Massart C, van den Driessche J, Gouffault J. Allain H, et al. Arch Mal Coeur Vaiss. 1982 Sep;75(9):951-62. Arch Mal Coeur Vaiss. 1982. PMID: 6816179 French.
• [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].

  Werning C. Werning C. Med Klin. 1973 Nov 23;68(47):1559-63. Med Klin. 1973. PMID: 4781097 German. No abstract available.
• Plasma prolactin in essential and renovascular hypertension.

  Modlinger RS, Gutkin M. Modlinger RS, et al. J Lab Clin Med. 1978 Apr;91(4):693-7. J Lab Clin Med. 1978. PMID: 641393